ULURU: Funding, Investors & Team (Oct 2026)
ULURU is a company that specializes in pharmaceuticals and focuses on the research, development, and commercialization of wound care and mucoadhesive film products worldwide. Their products utilize patented technologies called Nanoflex and OraDisc for drug delivery. The company offers various products including Altrazeal, a powder dressing that can transform and aid in the treatment of different types of wounds like burns and abrasions, as well as surgical or chronic wounds. They also provide Aphthasol and Aptheal for treating canker sores, as well as OraDisc A for oral conditions that require medication in gel or paste form applied to mouth lesions, and OraDisc B, a mucoadhesive disc for managing oral pain. Established in 1987, the company is headquartered in Addison, Texas.
ULURU has raised $2.2M across 1 funding round on record, the most recent an undisclosed round of $2.2M announced in Sep 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ULURU Company Profile and Key Stats
Latest funding round on record: Sep 2023.
ULURU Funding Rounds
ULURU Founders and Leadership Team
No contact details are on record for this team yet.
ULURU Funding Compared to Other Biotechnology Startups
ULURU's latest round of $2.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ULURU in Biotechnology and Addison
Companies Similar to ULURU
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
ULURU Funding FAQs
What does ULURU do?
ULURU is a company that specializes in pharmaceuticals and focuses on the research, development, and commercialization of wound care and mucoadhesive film products worldwide. Their products utilize patented technologies called Nanoflex and OraDisc for drug delivery. The company offers various products including Altrazeal, a powder dressing that can transform and aid in the treatment of different types of wounds like burns and abrasions, as well as surgical or chronic wounds. They also provide Aphthasol and Aptheal for treating canker sores, as well as OraDisc A for oral conditions that require medication in gel or paste form applied to mouth lesions, and OraDisc B, a mucoadhesive disc for managing oral pain. Established in 1987, the company is headquartered in Addison, Texas.
How much funding has ULURU raised?
ULURU has raised $2.2M across 1 round on record. The most recent is an undisclosed round of $2.2M announced in Sep 2023.
When did ULURU last raise funding?
ULURU's most recent funding round on record is an undisclosed round of $2.2M, announced in Sep 2023.
Who is the CEO of ULURU?
Kerry Gray is listed as CEO at ULURU.
Where is ULURU headquartered?
ULURU is based in Addison, Texas, United States.
How many employees does ULURU have?
ULURU is in the 11-50 employee band.
How does ULURU's funding compare to other Biotechnology startups?
ULURU's latest round of $2.2M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's ULURU Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ULURU is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.